Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: WST

West Pharmaceutical Services, Inc.

Healthcare | Medical - Instruments & Supplies

Market prices for WST are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$7.81

West Pharmaceutical Services, Inc. (NYSE: WST) is a medical instruments and supplies company. Figures from SEC EDGAR; updated 2026-10-20 06:48 UTC.

What West Pharmaceutical Services, Inc. does

The company is a global manufacturer of integrated containment and delivery systems for injectable drugs and healthcare products, serving biologic, pharmaceutical, and medical device companies. It operates through two segments: Proprietary Products, which offers elastomer-based packaging, drug delivery devices, and analytical services with facilities across North America, South America, Europe, and Asia; and Contract-Manufactured Products, which designs and manufactures complex devices using advanced molding and assembly technologies with facilities in North America and Europe.

Summarized from West Pharmaceutical Services, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$7.81
Return on equity15.54%
Debt/equity0.07

Revenue, margins & earnings

FY2021 Net income: $662MFY2021 Taxes & interest: $90MFY2021 Operating expenses: $424MFY2021 Cost of revenue: $1.66B$2.83BFY2021FY2022 Net income: $586MFY2022 Taxes & interest: $148MFY2022 Operating expenses: $402MFY2022 Cost of revenue: $1.75B$2.89BFY2022FY2023 Net income: $593MFY2023 Taxes & interest: $83MFY2023 Operating expenses: $453MFY2023 Cost of revenue: $1.82B$2.95BFY2023FY2024 Net income: $493MFY2024 Taxes & interest: $77MFY2024 Operating expenses: $429MFY2024 Cost of revenue: $1.89B$2.89BFY2024FY2025 Net income: $494MFY2025 Taxes & interest: $91MFY2025 Operating expenses: $519MFY2025 Cost of revenue: $1.97B$3.07BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-02
  • 2026-10-02DirectorPhantom Stock UnitAward44$16.3K
  • 2026-09-15Sr. VP & Chief HR OfficerSale-2,500$887.5K
  • 2026-09-15Sr. VP & Chief HR OfficerStock Option (Right to Buy)Option exercise-2,500—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does West Pharmaceutical Services, Inc. do?

The company is a global manufacturer of integrated containment and delivery systems for injectable drugs and healthcare products, serving biologic, pharmaceutical, and medical device companies.

When did WST last file with the SEC?

West Pharmaceutical Services, Inc.'s most recent SEC filing on record is a SCHEDULE 13G filed 2026-08-06. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 06:48 UTC. This page is also available as JSON at /api/data?ticker=WST and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for WST and 5,000+ tickers.

Create a free account — keep WST
For your agent
GET /api/data?ticker=WST

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt